ALDX

Insider trade Purchase by DOUGLAS RICHARD

74d ago

Insider trade Purchase by Michael Alfieri (Principal Financial Officer)

74d ago

News Aldeyra plunges as FDA rejects dry eye disease therapy

77d ago

SEC filing ALDX Receives FDA Complete Response Letter for Reproxalap NDA, $70M Cash Supports 2028 Ops

77d ago

News Catalyst Watch: Nvidia's GTC Conference, FOMC meeting, Okta event, and triple-witching day

81d ago

News Mid to low cap healthcare stocks with the strongest earnings momentum

137d ago

News Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases

145d ago

News Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease – Company Announcement - FT.com

168d ago

Scanner Unusual volume (z=2.6)

168d ago

News Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease – Company Announcement - FT.com

168d ago